图片来源:视觉中国近日,彭博社援引知情人士消息报道,总部位于新泽西的传奇生物(Legend Biotech)正在考虑在美国境外进行第二次上市,潜在地点包括中国香港、新加坡和伦敦。目前,公司已与潜在顾问展开沟通,但相关谈判细节尚未公开。近年来细胞治疗领域颇受关注,但多数CAR-T企业仍然面临亏损,因为Carvykti(西达基奥仑赛)一战成名的传奇生物同样处于亏损阶段。业绩大涨但仍处亏损,竞争对手实力...
Source Link图片来源:视觉中国近日,彭博社援引知情人士消息报道,总部位于新泽西的传奇生物(Legend Biotech)正在考虑在美国境外进行第二次上市,潜在地点包括中国香港、新加坡和伦敦。目前,公司已与潜在顾问展开沟通,但相关谈判细节尚未公开。近年来细胞治疗领域颇受关注,但多数CAR-T企业仍然面临亏损,因为Carvykti(西达基奥仑赛)一战成名的传奇生物同样处于亏损阶段。业绩大涨但仍处亏损,竞争对手实力...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.